In the integumentary system, GLP-1 RAs show promise in managing psoriasis and enhancing diabetic wound healing through anti-inflammatory pathways and keratinocyte migration, but they can cause rare dermatological side effects like hypersensitivity reactions and eosinophilic panniculitis. The gene discussed is GLP1R; the disease is psoriasis.